Trial Profile
A random, paralleled, double-blinded, placebo controlled clinical study of tolerability of ulinastat
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Ulinastatin (Primary)
- Indications Pancreatitis; Severe acute respiratory syndrome; Vascular disorders
- Focus Adverse reactions
- Sponsors Techpool Bio-Pharma
- 28 Apr 2016 New trial record